Germ cell tumor risk factors: Difference between revisions
Jump to navigation
Jump to search
Hudakarman (talk | contribs) (Created page with "==Risk Factors== *Ovarian germ cell tumors tend to affect individuals with gonadal dysgenesis at a greater extent.<ref name="PleskacovaHersmus2010">{{cite jour...") |
Hudakarman (talk | contribs) No edit summary |
||
| Line 15: | Line 15: | ||
===Dysgerminoma=== | ===Dysgerminoma=== | ||
*Common [[risk factors]] in the [[development]] of [[dysgerminoma]] are [[gonadal dysgenesis]], [[androgen insensitivity syndrome]] and [[gonadoblastoma]].<ref name="wqd">{{cite book | last = Kliegman | first = Robert | title = Nelson textbook of pediatrics | publisher = Elsevier/Saunders | location = Philadelphia, PA | year = 2011 | isbn = 978-1-4377-0755-7 }}</ref> | *Common [[risk factors]] in the [[development]] of [[dysgerminoma]] are [[gonadal dysgenesis]], [[androgen insensitivity syndrome]] and [[gonadoblastoma]].<ref name="wqd">{{cite book | last = Kliegman | first = Robert | title = Nelson textbook of pediatrics | publisher = Elsevier/Saunders | location = Philadelphia, PA | year = 2011 | isbn = 978-1-4377-0755-7 }}</ref> | ||
==References== | |||
{{reflist|2}} | |||
Revision as of 18:15, 19 August 2019
Risk Factors
- Ovarian germ cell tumors tend to affect individuals with gonadal dysgenesis at a greater extent.[1]
- Maternal hormonal factors are another things associated with the increased risk of the development of ovarian germ cell tumors in daughters. These factors include:[2][3][4]
- Maternal use of exogenous hormones (ie, supportive hormones or oral contraceptives)
- Maternal high body mass index
- Other reproductive factors also has been observed to be associated with the development of these tumors such as:
- Parity
- Oral contraceptive use
- Age at first and last births
Mature teratoma
- Common risk factors in the malignant transformation of mature teratoma include:
Dysgerminoma
- Common risk factors in the development of dysgerminoma are gonadal dysgenesis, androgen insensitivity syndrome and gonadoblastoma.[7]
References
- ↑ Pleskacova, J.; Hersmus, R.; Oosterhuis, J.W.; Setyawati, B.A.; Faradz, S.M.; Cools, M.; Wolffenbuttel, K.P.; Lebl, J.; Drop, S.L.; Looijenga, L.H. (2010). "Tumor Risk in Disorders of Sex Development". Sexual Development. 4 (4–5): 259–269. doi:10.1159/000314536. ISSN 1661-5433.
- ↑ Sharpe, Richard M.; Skakkebaek, Niels E. (2008). "Testicular dysgenesis syndrome: mechanistic insights and potential new downstream effects". Fertility and Sterility. 89 (2): e33–e38. doi:10.1016/j.fertnstert.2007.12.026. ISSN 0015-0282.
- ↑ Skakkebæk, N.E.; Rajpert-De Meyts, E.; Main, K.M. (2001). "Testicular dysgenesis syndrome: an increasingly common developmental disorder with environmental aspects: Opinion". Human Reproduction. 16 (5): 972–978. doi:10.1093/humrep/16.5.972. ISSN 1460-2350.
- ↑ Walker AH, Ross RK, Haile RW, Henderson BE (April 1988). "Hormonal factors and risk of ovarian germ cell cancer in young women". Br. J. Cancer. 57 (4): 418–22. PMC 2246577. PMID 3390378.
- ↑ Hackethal A, Brueggmann D, Bohlmann MK, Franke FE, Tinneberg HR, Münstedt K (December 2008). "Squamous-cell carcinoma in mature cystic teratoma of the ovary: systematic review and analysis of published data". Lancet Oncol. 9 (12): 1173–80. doi:10.1016/S1470-2045(08)70306-1. PMID 19038764.
- ↑ Park, Jeong-Yeol; Kim, Dae-Yeon; Kim, Jong-Hyeok; Kim, Yong-Man; Kim, Young-Tak; Nam, Joo-Hyun (2008). "Malignant transformation of mature cystic teratoma of the ovary: Experience at a single institution". European Journal of Obstetrics & Gynecology and Reproductive Biology. 141 (2): 173–178. doi:10.1016/j.ejogrb.2008.07.032. ISSN 0301-2115.
- ↑ Kliegman, Robert (2011). Nelson textbook of pediatrics. Philadelphia, PA: Elsevier/Saunders. ISBN 978-1-4377-0755-7.